Cardiovascular disease in children with chronic kidney disease

Area of Science:

• Pediatric Nephrology
• Cardiovascular Research
• Clinical Medicine

Background:

• Cardiovascular disease (CVD) is a leading cause of mortality in children with advanced chronic kidney disease (CKD).
• Children with CKD exhibit a high prevalence of traditional and uremia-related CVD risk factors, mirroring adult populations.
• Early indicators of cardiac and vascular damage are common in pediatric CKD patients, particularly those on dialysis.

Purpose of the Study:

• To assess cardiovascular risk, disease mechanisms, and early CVD markers in children with CKD.
• To highlight the significant benefit of proactive CVD prevention and treatment in this vulnerable pediatric population.
• To emphasize the critical window for intervention in early-stage CKD.

Main Methods:

• Review of studies investigating cardiovascular risk factors in pediatric CKD.
• Assessment of early markers of cardiomyopathy (e.g., left ventricular hypertrophy) and atherosclerosis (e.g., carotid artery intima-media thickness, coronary artery calcification).
• Analysis of risk factors in children with CKD, including those on maintenance dialysis.

Main Results:

• Children with CKD have a high prevalence of traditional and uremia-related CVD risk factors.
• Early markers of cardiomyopathy and atherosclerosis are frequently observed, especially in children on maintenance dialysis.
• Intervention in early CKD stages allows for identification and management of modifiable risk factors.

Conclusions:

• Early CKD presents an optimal opportunity to identify and manage cardiovascular risk factors.
• Slowing CKD progression, avoiding dialysis, and considering preemptive transplantation are key strategies to reduce premature cardiac disease and mortality.
• Aggressive CVD prevention and treatment strategies are essential for children with CKD.